Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: ALL who wrote (5015)	7/29/1998 11:58:00 AM
From: Izzy	of 6136

ALL, as Rick and I alluded to several posts ago (? few mos ago), and from what I know, AGPH is attempting some modification of Viracept (details not known). I think that Viracept can safely be given BID but, for most drugs, it is difficult to maintain a constant therapeutic blood level extending past 8 hrs. But cardiac, hypertensive, etc. patients readily take their medications TID/QID without major problems altho' some drugs can now be taken qd (one time daily). Regarding any difficulty taking HIV drugs, perhaps some of the SI posters (eg., BriBear, Cherry Grove) can give some insight. PS: Some people were concerned about high Viracept inventories. Just look at the problems with Norvir. How could an M.D. prescribe this drug when it is not even known if it will be acceptable/available? Really safer to just stay with Viracept, IMO.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next